ImmutriX Therapeutics, Inc., a South Dakota Corporation (the “Company” or “ImmutriX”) was formed to develop and commercialize proprietary extracorporeal therapeutic treatments using proprietary adsorbent technologies. The Company’s research and development to date has provided the basis for the first series of medical device products using proprietary formulas of adsorbent materials removal of drugs and poisons.